In hereditary cancers, somatic mutation is the main mechanism for hMLH1 gene inactivation; in sporadic cancers, epigenetic hMLH1 silencing by promoter hypermethylation appears to be involved (27,28). This evidence concerns the gene MLH1 and hereditary cancer.